360 related articles for article (PubMed ID: 24021342)
1. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M
Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342
[TBL] [Abstract][Full Text] [Related]
2. Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Guckenberger M; Saur G; Wehner D; Sweeney RA; Thalheimer A; Germer CT; Flentje M
Strahlenther Onkol; 2012 Jul; 188(7):551-7. PubMed ID: 22638934
[TBL] [Abstract][Full Text] [Related]
3. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer -- impact on long-term quality of life.
Kripp M; Wieneke J; Kienle P; Welzel G; Brade J; Horisberger K; Wenz F; Post S; Gencer D; Hofmann WK; Hofheinz RD
Eur J Surg Oncol; 2012 Jun; 38(6):472-7. PubMed ID: 22349986
[TBL] [Abstract][Full Text] [Related]
4. The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).
McLachlan SA; Fisher RJ; Zalcberg J; Solomon M; Burmeister B; Goldstein D; Leong T; Ackland SP; McKendrick J; McClure B; Mackay J; Ngan SY
Eur J Cancer; 2016 Mar; 55():15-26. PubMed ID: 26771873
[TBL] [Abstract][Full Text] [Related]
5. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of neoadjuvant chemoradiotherapy followed by sphincter-preserving resection on anal sphincter function in relation to quality of life among locally advanced rectal cancer patients: a cross-sectional analysis.
Ozgen Z; Ozden S; Atasoy BM; Ozyurt H; Gencosmanoglu R; Imeryuz N
Radiat Oncol; 2015 Aug; 10():168. PubMed ID: 26264590
[TBL] [Abstract][Full Text] [Related]
7. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.
Wiltink LM; Nout RA; van der Voort van Zyp JR; Ceha HM; Fiocco M; Meershoek-Klein Kranenbarg E; Marinelli AW; van de Velde CJ; Marijnen CA
Clin Colorectal Cancer; 2016 Sep; 15(3):e93-9. PubMed ID: 26968237
[TBL] [Abstract][Full Text] [Related]
10. Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial.
Tiv M; Puyraveau M; Mineur L; Calais G; Maingon P; Bardet E; Mercier M; Bosset JF
Cancer Radiother; 2010 Oct; 14(6-7):530-4. PubMed ID: 20797891
[TBL] [Abstract][Full Text] [Related]
11. Late side effects and quality of life after radiotherapy for rectal cancer.
Bruheim K; Guren MG; Skovlund E; Hjermstad MJ; Dahl O; Frykholm G; Carlsen E; Tveit KM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1005-11. PubMed ID: 19540058
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study.
Senyurek S; Saglam S; Saglam EK; Yanar H; Gok K; Tastekin D; Akbas CK; Sakin ND; Kartal GD; Balik E; Keskin M; Sanli Y; Gulluoglu M; Akgun Z
Oncol Res; 2023; 31(5):689-696. PubMed ID: 37547762
[TBL] [Abstract][Full Text] [Related]
13. Influence of neoadjuvant radiochemotherapy combined with hyperthermia on the quality of life in rectum cancer patients.
Schulze T; Wust P; Gellermann J; Hildebrandt B; Riess H; Felix R; Rau B
Int J Hyperthermia; 2006 Jun; 22(4):301-18. PubMed ID: 16754351
[TBL] [Abstract][Full Text] [Related]
14. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
Brændengen M; Tveit KM; Bruheim K; Cvancarova M; Berglund Å; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1017-24. PubMed ID: 20932687
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
[TBL] [Abstract][Full Text] [Related]
16. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
17. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
18. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J
J Clin Oncol; 2012 Nov; 30(31):3827-33. PubMed ID: 23008301
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
